Article
Comparison of the efficacy and safety of first-line treatments based on clinicopathological characteristics for patients with advanced epidermal growth factor receptor mutated non-small-cell lung cancer: A systematic review and network meta-analysis.
Critical reviews in oncology/hematology - 1 Sept 2022
Yang Fei, Zhang Wengang, Shang Xiaoling, Liu Ni, Ma Xinchun, Qin Jing, Zhang Yuqing, Liu Yanguo, Wang Xiuwen
Abstract excerpt
BACKGROUND: A growing number of regimens have been approved as first-line treatments for patients with advanced epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer. However, the optimal regimen has not been determined, especially for patients with different clinicopathological characteristics. Therefore, we performed this meta-analysis to compare the efficacy and safety of first-line...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.